August 29, 2025

Updated Approaches Strengthen Osteoporosis Risk Management

Updated osteoporosis management emphasizes improved risk prediction, lifestyle strategies, and stepwise therapy to reduce future fractures.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

High Brain Pain Activity Tied to Better RA Outcomes

"These data highlight the role of subjective patient-related parameters in the response to cytokine inhibition and suggest that a high-volume representation of the disease in the CNS—involving more frontal-associative brain circuits—increases the likelihood to respond to TNF inhibitor.

Conexiant

August 21, 2025

Six Evidence-Based Strategies Transform Clinical Listening

New research identifies six practical approaches to values-driven listening that enhance patient trust, reduce burnout, and improve care quality.

Conexiant

August 19, 2025

Neck Swelling, Dysphagia, and Jaw Pain: What’s Your Diagnosis?

A rare carotid artery pseudoaneurysm complicated by MRSA infection, septic arthritis, and an incidental thigh tumor challenged clinicians but was successfully treated with surgery and targeted antibiotics.

Conexiant

August 17, 2025

Ultrasound Distinguishes Psoriatic Arthritis Phenotypes

Imaging split psoriatic arthritis into two inflammatory subtypes.

Conexiant

August 15, 2025

FDA Approves Non-Opioid Fibromyalgia Therapy

Tonmya reduces fibromyalgia pain versus placebo in phase 3 trials, offering a non-opioid option with a generally well-tolerated safety profile.

Conexiant

August 14, 2025

Low Bone Quality in RA Tied to Diabetes, Study Shows

Trabecular bone score identifies high rates of vertebral bone quality loss in women with rheumatoid arthritis, regardless of corticosteroid use.

Conexiant